In trading today, Fennec Pharmaceuticals Inc shares closed at $12.80 after opening the day at $12.75. Intraday prices ranged from a low of $12.75 to a high of $12.81.

Shares eased -0.16 percent from the previous day's close of $12.82.

During the day across North America, the TSX Composite closed tsx_percentage_change% at 21807.37, the S&P 500 closed sp_500_percentage_change% at 4967.23, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37986.40 and the Nasdaq Composite closed nasdaq_percentage_change% at 15282.01.

Fennec Pharmaceuticals Inc traded under FRX on the Toronto Stock Exchange (TSX).

A total of 800 shares was traded during the session, with total trades of 8, while having an average volume of 360 in the last five days.

The TSX overall saw 3,754 price advancers against 1,430 declines and 130 unchanged.

During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $9.27 (October 06,2023). Moreover, the shares have advanced 21.10% in the last 12 months, while they have shrunken -15.57% year-to-date.

Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $347.42 million on a float of 27,100 shares outstanding. Its annual EPS is $-0.60.

Fennec Pharmaceuticals Inc is a None company headquartered in Research Triangle Park, USA.

Currently, Fennec Pharmaceuticals Inc's consensus rating is "Strong Buy" based on 6 analysts according to Zacks. From those 6 analysts, 6 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..